Chocolated Laxative
Natural health product licensed in Canada
- Other names
- Chocolate-Flavoured Laxative
- Licence holder
- Northstar Pharmaceutical Inc.
- NPN or DIN-HM
- 80079621
- Status
- Active licence
- Licence date
- 22 August 2017
- Revision date
- 8 March 2019
- Form
- Comprimé, à croquer
- Route of administration
- Orale
- Application type
- TPD Cat IV/LS
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Sennoside A&B Source : Sennoside de calcium | 15 milligramme | Not calculated |
Non-medicinal ingredients
Lécithine, Vanille (de Tahiti), Lactosérum doux, Sucrose, Chlorure de sodium, Huile végétale partiellement hydrogénée, Poudre de cacao
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes et adolescents | minimum: 12 years | minimum: 1 Comprimé ; maximum: 2 Comprimé | minimum: 1 day ; maximum: 2 days |
Uses authorised in Canada
Stimulant laxative. Relief of occasional constipation.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a health care practitioner if symptoms persist or worsen. Consult a health care practitioner prior to use if you are taking thiazide diuretics, corticosteroids, licorice root or other medications or health products which may aggravate electrolyte imbalance or if you have a kidney disorder or are taking cardiac medications such as cardiac glycosides or antiarrhythmic medications or have faecal impaction or symptoms such as abdominal pain, nausea, vomiting or fever. Reduce dose or discontinue use if you experience abdominal pain, cramps, spasms and/or diarrhoea.
- Contre-indications
Do not use if you are pregnant or breastfeeding or have abnormal constrictions of the gastrointestinal tract, potential or existing intestinal blockage, atonic bowel, appendicitis, inflammatory colon disease such as Crohn's disease or ulcerative colitis, abdominal pain of unknown origin, undiagnosed rectal bleeding, severe dehydration with depleted water or electrolytes.
Source
Official Health Canada record, licence 80079621
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2019. Photograph the packaging to check whether it has changed. Photograph the packaging